Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Neurotrophin 3 ELISA Kit (AC2981)
Cat.#: ASET-1570
Specifications
Description Human Neurotrophin 3 ELISA Kit allows for the in vitro quantitative determination of human Neurotrophin 3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2053 Monkey Fetuin A ELISA Kit (AC3464) Quantitative inquiry ASET-1026 Human Cadherin 8 ELISA Kit (AC2437) Quantitative inquiry ASET-1056 Human EN2 ELISA Kit (AC2467) Quantitative inquiry ASET-1495 Mouse Dopamine Receptor D1 ELISA Kit (AC2906) Quantitative inquiry ASET-2304 Mouse MEF2A ELISA Kit (AC3715) Quantitative inquiry ASET-2140 Rat Laminin ELISA Kit (AC3551) Quantitative inquiry ASET-1294 Rat beta Arrestin 1 ELISA Kit (AC2705) Quantitative inquiry ASET-1720 Rat JNK3 ELISA Kit (AC3131) Quantitative inquiry ASET-2442 Human Ephrin B2 ELISA Kit (AC3853) Quantitative inquiry ASET-1545 Mouse Dystrophin ELISA Kit (AC2956) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket